Keyphrases
Thrombocytopenia
100%
Therapeutic Potential
100%
Chronic Hepatitis C
100%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
100%
Antiviral Therapeutics
100%
Hepatitis C
100%
Genotype
80%
IL28B
80%
Sustained Virological Response
80%
Inosine Triphosphatase
80%
Hepatitis C Virus Genotype 2
60%
Odds Ratio
40%
Platelets
40%
Hepatitis C Virus Genotypes
40%
Genotype 1
40%
Logistic Regression Analysis
20%
Hepatocellular Carcinoma
20%
Hemoglobin
20%
Ribavirin
20%
Pegylated Interferon
20%
Antiviral Treatment
20%
Rs8099917
20%
Ribavirin Treatment
20%
Splenectomy
20%
TT Genotype
20%
Treatment Discontinuation
20%
Partial Splenic Embolization
20%
CC Genotype
20%
Genotype 2
20%
Premature Discontinuation
20%
Hemoglobin Reduction
20%
Pretreatment Variables
20%
Genotype Models
20%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Resistance
100%
Antivirus Agent
100%
Thrombocytopenia
100%
Chronic Hepatitis C
100%
Interleukin 28B
80%
Inosine
80%
Hepatitis C Virus Genotype 2
60%
Ribavirin
40%
Hepatitis C Virus Genotype 1
40%
Liver Cell Carcinoma
20%
Prematurity
20%
Peginterferon
20%
Polyethylene Glycol
20%
Immunology and Microbiology
Insulin Resistance
100%
Homeostasis
100%
Hepatitis C
100%
Interleukin 28B
80%
Hepatitis C Virus Genotype 2
60%
Platelet
40%
Hepatitis C Virus Genotype 1
40%
Ribavirin
40%
Pegylated Interferon
20%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Thrombocytopenia
100%
Insulin Resistance
62%
Homeostasis
62%
Interleukin 28B
50%
Inosine Triphosphatase
50%
Hepatitis C Virus Genotype 2
37%
Hepatitis C Virus Genotype 1
25%
Ribavirin
25%
Platelet
25%
Interferon
12%